Full Text View
Tabular View
No Study Results Posted
Related Studies
Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
This study is currently recruiting participants.
Verified May 2013 by Stanford University
Study NCT01336803   Information provided by Stanford University

First Received on April 12, 2011.   Last Updated on May 6, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bone Cancer
Chondrosarcoma
Ewing's Sarcoma
Osteosarcoma
Rhabdomyosarcoma
Additional conditions recognized in this trial
Bone Neoplasms
Neuroectodermal Tumors, Primitive, Peripheral
Osteomyelitis
Sarcoma
Sarcoma, Ewing's
More general conditions related to this trial
Bone Diseases
Bone Diseases, Infectious
Infection
Musculoskeletal Diseases
Myosarcoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Bone Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Muscle Tissue
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Interventions listed in this trial
Feraheme
MR Scan
Additional drug interventions recognized in this trial
Ferumoxytol
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Stanford University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services